Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study

A long-term, open-label study of the safety and efficacy of oral tazarotene in moderate to very severe plaque psoriasis

10.1016/j.jaad.2003.10.012 ◽

2004 ◽

Vol 50 (3) ◽

pp. P2 ◽

Cited By ~ 1

Author(s):

Alan Menter ◽

Deborah Lew-Kaya ◽

Frederick Beddingfield ◽

Patricia S. Walker

Keyword(s):

Plaque Psoriasis ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Efficacy and Safety of Calcipotriol/Betamethasone Dipropionate Ointment for the Treatment of Trachyonychia: An Open-Label Study

Annals of Dermatology ◽

10.5021/ad.2015.27.4.371 ◽

2015 ◽

Vol 27 (4) ◽

pp. 371 ◽

Cited By ~ 9

Author(s):

Jung-Min Park ◽

Hyun-Ho Cho ◽

Won-Jeong Kim ◽

Je-Ho Mun ◽

Margaret Song ◽

...

Keyword(s):

Betamethasone Dipropionate ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Calcipotriol Betamethasone

Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.4.supp.38 ◽

2020 ◽

Vol 4 (5) ◽

pp. s38

Author(s):

Mark G Lebwohl ◽

Jeffrey Sugarman ◽

David M Pariser ◽

Jerry Bagel ◽

Cynthia Trickett ◽

...

Keyword(s):

Plaque Psoriasis ◽

Fixed Combination ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Abstract not available.

Pharmacokinetics and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: Results from a phase 2 open-label study

10.1016/j.jaad.2019.08.019 ◽

2020 ◽

Vol 82 (2) ◽

pp. 389-397 ◽

Cited By ~ 7

Author(s):

Amy S. Paller ◽

Ying Hong ◽

Emily M. Becker ◽

Raul de Lucas ◽

Maria Paris ◽

...

Keyword(s):

Plaque Psoriasis ◽

Pediatric Patients ◽

Phase 2 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Open-label study of etanercept treatment in patients with moderate-to-severe plaque psoriasis who lost a satisfactory response to adalimumab

British Journal of Dermatology ◽

10.1111/bjd.15381 ◽

2017 ◽

Vol 177 (2) ◽

pp. 411-418 ◽

Cited By ~ 4

Author(s):

J. Bagel ◽

S. Tyring ◽

K.C. Rice ◽

D.H. Collier ◽

G. Kricorian ◽

...

Keyword(s):

Plaque Psoriasis ◽

Open Label ◽

Etanercept Treatment ◽

Open Label Study ◽

Label Study ◽

Severe Plaque Psoriasis ◽

Satisfactory Response

Efficacy and safety of calcipotriol/betamethasone dipropionate ointment for the treatment of simple onycholysis: An open-label study

10.1016/j.jaad.2013.03.028 ◽

2013 ◽

Vol 69 (3) ◽

pp. 492-493 ◽

Cited By ~ 1

Author(s):

Jung-Min Park ◽

Je-Ho Mun ◽

Seung-Wook Jwa ◽

Margaret Song ◽

Hoon-Soo Kim ◽

...

Keyword(s):

Betamethasone Dipropionate ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Calcipotriol Betamethasone

Safety and efficacy of apremilast in pediatric patients with moderate to severe plaque psoriasis: Results from a phase 2 open-label study

10.1016/j.jaad.2019.06.455 ◽

2019 ◽

Vol 81 (4) ◽

pp. AB120

Keyword(s):

Plaque Psoriasis ◽

Pediatric Patients ◽

Phase 2 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Long‐term safety and efficacy of a fixed‐combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate‐to‐severe plaque psoriasis: phase 3 open‐label study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.17113 ◽

2021 ◽

Author(s):

M.G. Lebwohl ◽

L. Stein Gold ◽

K. Papp ◽

G. Han ◽

D.M. Pariser ◽

...

Keyword(s):

Plaque Psoriasis ◽

Fixed Combination ◽

Open Label ◽

Phase 3 ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Long-term safety results from a phase 3 open-label study of a fixed combination halobetasol propionate 0.01% and tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis

10.1016/j.jaad.2018.09.002 ◽

2019 ◽

Vol 80 (1) ◽

pp. 282-285 ◽

Cited By ~ 8

Author(s):

Mark G. Lebwohl ◽

Jeffrey L. Sugarman ◽

Linda Stein Gold ◽

David M. Pariser ◽

Tina Lin ◽

...

Keyword(s):

Plaque Psoriasis ◽

Fixed Combination ◽

Open Label ◽

Phase 3 ◽

Open Label Study ◽

Label Study ◽

25709 Halobetasol propionate lotion 0.05% in patients 12 to 16 years 11 months of age with plaque psoriasis: Results from an open label study evaluating adrenal suppression potential

10.1016/j.jaad.2021.06.291 ◽

2021 ◽

Vol 85 (3) ◽

pp. AB66

Author(s):

Vivian Laquer ◽

David Davidson ◽

Andrea Nguyen ◽

Tien Nguyen

Keyword(s):

Plaque Psoriasis ◽

Adrenal Suppression ◽

Open Label ◽

Open Label Study ◽

Label Study